Lavigne P - Search Results

1

Pluronic F-127 as a cell carrier for bone tissue engineering.

Brunet-Maheu JM, Fernandes JC, de Lacerda CA, Shi Q, Benderdour M, Lavigne P. Brunet-Maheu JM, et al. Among authors: lavigne p. J Biomater Appl. 2009 Sep;24(3):275-87. doi: 10.1177/0885328208096534. Epub 2008 Nov 5. J Biomater Appl. 2009. PMID: 18987015

2

Evidence for two distinct pathways in TNFalpha-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients.

Shi Q, Benderdour M, Lavigne P, Ranger P, Fernandes JC. Shi Q, et al. Among authors: lavigne p. Osteoarthritis Cartilage. 2007 Mar;15(3):300-8. doi: 10.1016/j.joca.2006.08.010. Epub 2006 Dec 11. Osteoarthritis Cartilage. 2007. PMID: 17161959

3

Subchondral and trabecular bone metabolism regulation in canine experimental knee osteoarthritis.

Lavigne P, Benderdour M, Lajeunesse D, Reboul P, Shi Q, Pelletier JP, Martel-Pelletier J, Fernandes JC. Lavigne P, et al. Osteoarthritis Cartilage. 2005 Apr;13(4):310-7. doi: 10.1016/j.joca.2004.12.015. Osteoarthritis Cartilage. 2005. PMID: 15780644

4

Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis.

Fernandes JC, Wang H, Jreyssaty C, Benderdour M, Lavigne P, Qiu X, Winnik FM, Zhang X, Dai K, Shi Q. Fernandes JC, et al. Among authors: lavigne p. Mol Ther. 2008 Jul;16(7):1243-51. doi: 10.1038/mt.2008.99. Epub 2008 May 20. Mol Ther. 2008. PMID: 18500247

5

Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases?

Lavigne P, Benderdour M, Shi Q, Lajeunesse D, Fernandes JC. Lavigne P, et al. Expert Opin Biol Ther. 2005 Mar;5(3):313-20. doi: 10.1517/14712598.5.3.313. Expert Opin Biol Ther. 2005. PMID: 15833069 Review.

6

Characterization of folate-chitosan-DNA nanoparticles for gene therapy.

Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, Beaumont E, Fernandes JC. Mansouri S, et al. Among authors: lavigne p. Biomaterials. 2006 Mar;27(9):2060-5. doi: 10.1016/j.biomaterials.2005.09.020. Epub 2005 Oct 3. Biomaterials. 2006. PMID: 16202449

7

An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro.

Fernandes JC, Shi Q, Benderdour M, Lajeunesse D, Lavigne P. Fernandes JC, et al. Among authors: lavigne p. J Bone Miner Metab. 2008;26(6):543-50. doi: 10.1007/s00774-008-0866-0. Epub 2008 Nov 1. J Bone Miner Metab. 2008. PMID: 18979153 Free PMC article.

8

Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal.

Shi Q, Vaillancourt F, Côté V, Fahmi H, Lavigne P, Afif H, Di Battista JA, Fernandes JC, Benderdour M. Shi Q, et al. Among authors: lavigne p. Arthritis Res Ther. 2006;8(6):R159. doi: 10.1186/ar2066. Arthritis Res Ther. 2006. PMID: 17042956 Free PMC article.

9

Metabolic activity of osteoblasts retrieved from osteoarthritic patients after stimulation with mediators involved in periprosthetic loosening.

Lavigne P, Shi Q, Lajeunesse D, Dehnade F, Fernandes JC. Lavigne P, et al. Bone. 2004 Mar;34(3):478-86. doi: 10.1016/j.bone.2003.10.006. Bone. 2004. PMID: 15003795

10

Design and dynamic culture of 3D-scaffolds for cartilage tissue engineering.

El-Ayoubi R, DeGrandpré C, DiRaddo R, Yousefi AM, Lavigne P. El-Ayoubi R, et al. Among authors: lavigne p. J Biomater Appl. 2011 Jan;25(5):429-44. doi: 10.1177/0885328209355332. Epub 2009 Dec 30. J Biomater Appl. 2011. PMID: 20042429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results